Listed

HCA Healthcare, Inc.

HCANYSECIK 860730HealthcareFiscal year ends Dec 31

Reports and events: 370 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

HCA Healthcare, Inc., Reports and events
FiledFormWhat it isAccession number
2021-05-0416:35 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-150111
2021-04-3016:38 ET10-QQuarterly reportPeriod 2021-03-310001193125-21-145306
2021-04-2208:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-125676
2021-04-0917:08 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-111694
2021-03-1916:54 ETDEF 14AProxy statementPeriod 2021-04-280001193125-21-087653
2021-02-1916:28 ET10-KAnnual reportPeriod 2020-12-310001193125-21-048994
2021-02-0208:09 ET8-K1.02 Termination of a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-025346
2020-10-2916:22 ET10-QQuarterly reportPeriod 2020-09-300001193125-20-281070
2020-10-2608:16 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-276104
2020-10-0817:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-266399
2020-07-3018:51 ET10-QQuarterly reportPeriod 2020-06-300001193125-20-204191
2020-07-2208:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-196820
2020-05-0617:04 ET10-QQuarterly reportPeriod 2020-03-310001193125-20-135021
2020-05-0617:01 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-135015
2020-04-2108:54 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-112965
2020-04-0216:31 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-096038
2020-03-2017:18 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-080819
2020-03-2016:18 ETDEF 14AProxy statementPeriod 2020-05-010001193125-20-080679
2020-02-2617:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-20-050213
2020-02-2016:20 ET10-KAnnual reportPeriod 2019-12-310001193125-20-043524
2020-02-1217:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-033383
2020-02-1107:53 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-030658
2020-01-2808:52 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-016154
2019-11-2116:41 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-19-297641
2019-11-0116:33 ET10-QQuarterly reportPeriod 2019-09-300001193125-19-281996
2019-10-2908:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-277113
2019-10-1016:31 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-19-265871
2019-08-0216:46 ET10-QQuarterly reportPeriod 2019-06-300001193125-19-212115
2019-07-3009:04 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-206299
2019-07-2216:20 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-19-199011
2019-06-1216:49 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-19-171339
2019-06-0716:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-168266
2019-05-0317:54 ET10-QQuarterly reportPeriod 2019-03-310001193125-19-135292
2019-05-0216:20 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-19-135052
2019-04-3008:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-127530
2019-04-0217:04 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-19-095729
2019-03-1516:31 ETDEF 14AProxy statementPeriod 2019-04-260001193125-19-076774
2019-02-2517:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-19-050027
2019-02-2116:37 ET10-KAnnual reportPeriod 2018-12-310001193125-19-047078
2019-01-3017:03 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-19-022657
2019-01-2909:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-019842
2019-01-2216:40 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-014056
2019-01-1708:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-010996
2018-12-2116:31 ET8-K5.02 Departure or appointment of officers or directors0001193125-18-356414
2018-11-0616:48 ET10-QQuarterly reportPeriod 2018-09-300001193125-18-319640
2018-10-3008:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-311386
2018-09-1217:11 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-271892
2018-08-2316:44 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-18-256366
2018-08-1317:22 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-247443
2018-08-0316:44 ET10-QQuarterly reportPeriod 2018-06-300001193125-18-238342

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.